Donald Bunjes

Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2

Donald Bunjes, Conny Hardt, Martin Röllinghoff et al. · European Journal of Immunology · 1981 · 631 citations

Life Sciences, Immunology, Pharmacology +17

Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia.

Anders Österborg, Martin J.S. Dyer, Donald Bunjes et al. · Journal of Clinical Oncology · 1997 · 518 citations

Medicine, Oncology, Pharmacology +16

Survival of Patients with Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Study

Nelli Bejanyan, Daniel J. Weisdorf, Brent R. Logan et al. · Biology of Blood and Marrow Transplantation · 2014 · 354 citations · Full text

Medicine, Hematology, Oncology +17

Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial

Peter Dreger, Hartmut Döhner, Matthias Ritgen et al. · Blood · 2010 · 304 citations · Full text

Medicine, Immunology, Oncology +15

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

Nimitha R. Mathew, Francis Baumgartner, Lukas M. Braun et al. · Nature Medicine · 2018 · 289 citations · Full text

Medicine, Immunology, Oncology +7